| Symbol | NEPH |
|---|---|
| Name | NEPHROS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ 07079 |
| Telephone | 201.343.5202 |
| Fax | — |
| — | |
| Website | https://www.nephros.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001196298 |
| Description | Nephros Inc is a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets. Additional info from NASDAQ: |
Director Amron Arthur H 🟢 acquired 10.8K shares (2 derivative) of NEPHROS INC (NEPH) at $2.14 Transaction Date: May 11, 2026 | Filing ID: 000098
Read moreNew Form 10-K/A - NEPHROS INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020416 <b>Size:</b> 495 KB
Read moreNephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
Read moreNephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
Read moreBanks Robert R. Jr. 🟡 adjusted position in 10.4K shares (2 derivative) of NEPHROS INC (NEPH) at $2.14 Transaction Date: Mar 23, 2026 | Filing ID: 000053
Read more